The report also found that more than 60 percent of providers reported pharmacies making switches to generic drugs without notifying them. Providers overwhelmingly said they thought pharmacists should notify them when the switch was made, although 55 percent felt generics were safe and effective as corresponding brand-name products, according to the report.
Around half of the respondents said patient outcomes were impacted after switching to generic drugs.
More Articles on Physicians:
5 Methods for Spine Surgeons to Avoid Burn-Out From Dr. Amir Vokshoor
Dr. Charles Branch Receives AANS/CNS Award
10 Key Concepts for Patient-Friendly Spine Practices
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.